Prime Medicine (PRME) Earnings Date & Reports

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PRME is expected to report earnings to rise 41.94% to -43 cents per share on May 09

Prime Medicine PRME Stock Earnings Reports

Q1'25

Est.

$-0.44

Q4'24

Beat

by $0.18

Q3'24

Beat

by $0.05

Q2'24

Beat

by $0.03

Q1'24

Beat

by $0.07

The last earnings report on February 28 showed earnings per share of -31 cents, beating the estimate of -49 cents. With 962.57K shares outstanding, the current market capitalization sits at 234.78M.

View a ticker or compare two or three

Compare

PRME